← Back to Search

Lung transplant Recipients for Lung Disease

N/A
Recruiting
Led By Susan Mathai, MD
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Summary

A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.

Eligible Conditions
  • Lung Disease
  • Respiratory Failure
  • Interstitial Lung Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diagnosis of patients with lung transplant
Secondary outcome measures
Survival

Trial Design

1Treatment groups
Experimental Treatment
Group I: Lung transplant RecipientsExperimental Treatment1 Intervention
Biobank registry for Lung transplant recipients

Find a Location

Who is running the clinical trial?

Baylor Research InstituteLead Sponsor
205 Previous Clinical Trials
203,315 Total Patients Enrolled
Susan Mathai, MDPrincipal Investigator - Baylor Scott & White Research Institute
Baylor Research Institute
1 Previous Clinical Trials
49 Total Patients Enrolled
~26 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top